4 most recent filings and news items mentioning NEO. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/NEO/news?limit=20"
Pull NEO filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayNeoGenomics has resolved a civil settlement with the DOJ regarding a voluntary disclosure from 2021, agreeing to pay $9.8 million plus interest. This resolution allows the company to proceed with its strategic vision amidst managing a legacy matter.
View filing at SEC.gov →NeoGenomics appointed Carolyn Starrett to its Board of Directors. Her experience in oncology data and AI strengthens the company's leadership for precision medicine growth.
View filing at SEC.gov →NeoGenomics Inc. has issued convertible senior notes due 2032 with a 0.75% coupon rate, with U.S. Bank Trust Company serving as trustee. This debt offering provides the company with additional capital for operations and strategic initiatives.
View filing at SEC.gov →NeoGenomics announced pricing of $275 million in 0.75% convertible senior notes maturing July 1, 2032, with an additional $41.25 million option for underwriters. The notes carry an initial conversion price of $14.16 per share, representing a 35% premium to the June 16 closing pri
View filing at SEC.gov →